Affymetrix to Webcast Presentations for UBS West Coast Life Sciences & Diagnostics Tour
March 01 2007 - 5:49PM
Business Wire
Affymetrix, Inc. (Nasdaq:AFFX) today announced that the Company
will webcast presentations at 1:00 pm PT on Tuesday, March 6th in
Santa Clara, CA as part of the UBS West Coast Life Sciences and
Diagnostics Tour. The program will include�a general corporate
overview, as well as presentations on Affymetrix' Life Sciences and
Molecular Diagnostics businesses. The speakers will include: --
Doug Farrell, Vice President of Investor Relations -- Sean George,
Ph.D., Vice President of Life Sciences Research, Academic -- Noel
Doheny, Senior Vice President of Molecular Diagnostics The webcast
will include the Question and Answer session following the
presentations. A webcast will be available live and by replay. To
access both the live and archived webcast, please go to
www.affymetrix.com and click on the "Investors" link. The archived
replay will be available 24 hours after the live presentation and
will be accessible for 30 days. About Affymetrix Affymetrix
scientists invented the world's first high-density microarray in
1989 and began selling the first commercial microarray in 1994.
Since then, Affymetrix GeneChip� technology has become the industry
standard in molecular biology research. Affymetrix technology is
used by the world's top pharmaceutical, diagnostic and
biotechnology companies as well as leading academic, government and
not-for-profit research institutes. More than 1,400 systems have
been installed around the world and more than 8,500 peer-reviewed
papers have been published using the technology. Affymetrix'
patented photolithographic manufacturing process provides the most
information capacity available today on an array, enabling
researchers to use a whole-genome approach to analyzing the
relationship between genetics and health. Affymetrix is
headquartered in Santa Clara, Calif., with manufacturing facilities
in Sacramento, Calif., Bedford, Mass., and Singapore. The company
maintains important sales and marketing operations in Europe and
Asia, and has about 1,100 employees worldwide. For more information
about Affymetrix, please visit the company's website at
www.affymetrix.com. NOTE: Affymetrix, the Affymetrix logo and
GeneChip� are registered trademarks owned or used by Affymetrix
Inc.
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Jul 2024 to Aug 2024
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Aug 2023 to Aug 2024